Best Practice & Research Clinical Rheumatology
Volume 20, Issue 2 , Pages 315-328 , April 2006

Spondylarthropathies in children—are they different from those in adults?

  • Michaël Hofer, MD (Paediatric Rheumatologist)

      Affiliations

    • Corresponding Author InformationTel.: +41 21 314 3324; Fax: +41 21 314 3558.

References 

  1. Cabral DA, Oen KG, Petty RE. SEA syndrome revisited: a long-term follow-up of children with a syndrome of seronegative enthesopathy and arthropathy. The Journal of Rheumatology. 1992;19(8):1282–1285
  2. Petty RE, Cassidy JT. Juvenile ankylosing spondylitis. In:  Cassidy JT,  Petty RE editor. Textbook of Pediatric Rheumatology. 4th edn. Philadelphia, PA: WB Saunders; 2001;p. 323–344
  3. Burgos-Vargas R, Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. The Journal of Rheumatology. 1989;16(2):192–197
  4. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis and Rheumatism. 1991;34:1218–1227
  5. Prieur AM, Listrat V, Dougados M, Amor B. Criteria for classification of spondylarthropathies in children. Archives Francaises de Pediatrie. 1993;50(5):379–385
  6. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. The Journal of Rheumatology. 1998;25(10):1991–1994
  7. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. The Journal of Rheumatology. 2001;31(2):390–392
  8. Hofer MF, Mouy R, Prieur A-M. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. The Journal of Rheumatology. 2001;28:1083–1090
  9. Prieur AM. Spondylarthropathies in childhood. Bailleres Clinical Rheumatology. 1998;12:287–307
  10. Hofer MF, Southwood T. Classification of childhood arthritis. Best Practice and Research Clinical Rheumatology. 2002;16:379–396
  11. Foeldvari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. The Journal of Rheumatology. 2000;27:1069–1072
  12. Ramsey SE, Belaria RR, Cabral DA, et al. Comparison of criteria for the classification of childhood arthritis. The Journal of Rheumatology. 2000;27:1283–1286
  13. Merino R, de Inocencio J, Garcia-Consuegra J. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children. The Journal of Rheumatology. 2001;28:2731–2736
  14. Fantini F. Classification of chronic arthritis of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. The Journal of Rheumatology. 2001;28:456–458
  15. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much?. The Journal of Rheumatology. 2002;29(7):1520–1530
  16. Burgos-Vargas R, Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. The Journal of Rheumatology. 1989;16:192–197
  17. Gomez KS, Raza K, Jones SD, et al. Juvenile onset ankylosing spondylitis—more girls than we thought?. The Journal of Rheumatology. 1997;24:735–737
  18. Marcoux D, Prost Y. Pediatric psoriasis revisited. Journal of Cutaneous Medicine and Surgery. 2002;6(3 supplement):22–28
  19. Ferrandiz C, Bordas X, Garcia-Patos V, et al. Prevalence of psoriasis in Spain (Epiderma Project: phase I). Journal of the European Academy of Dermatology and Venereology. 2001;15:20–23
  20. Hamilton ML, Gladman DD, Shore A, et al. Juvenile psoriatic arthritis and HLA antigens. Annals of the Rheumatic Diseases. 1990;49(9):694–697
  21. Roberton DM, Cabral DA, Malleson PN, Petty RE. Juvenile psoriatic arthritis: follow-up and evaluation of diagnostic criteria. The Journal of Rheumatology. 1996;23(1):166–170
  22. Garcia-Consuegra Molina J, Merino Munoz R, Fernandez Revuelta S, Soler Balda C. Juvenile spondyloarthropathies: descriptive study of 40 patients. Annals of Espanoles in Pediatrics. 1998;48:489–494
  23. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis and Rheumatism. 1998;41:58–67
  24. Cabral DA, Tucker LB. Malignancies in children who initially present with rheumatic complaints. Journal of Pediatric. 1999;134:53–57
  25. Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Annals of the Rheumatic Diseases. 2005;64(6):871–874
  26. Cabral DA, Malleson PN, Petty RE. Spondyloarthropathies of childhood. Pediatric Clinics of North America. 1995;42(5):1051–1070
  27. Manners P, Lesslie J, Speldewinde D, Tunbridge D. Classification of juvenile idiopathic arthritis: should family history be included in the criteria?. The Journal of Rheumatology. 2003;30(8):1857–1863
  28. Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 2004;111:802–809
  29. Jimenez-Balderas FJ, Garcia-Rubi D, Perez-Hinojosa S, et al. Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology. 2001;52:543–548
  30. Camiciottoli G, Trapani S, Ermini M, et al. Pulmonary function in children affected by juvenile spondyloarthropathy. The Journal of Rheumatology. 1999;26(6):1382–1386
  31. Bollow M, Braun J, Biedermann T, et al. Use of contrast-enhanced MR imaging to detect sacroiliitis in children. Skeletal Radiology. 1998;27(11):606–616
  32. Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J. Juvenile-onset spondyloarthropathies. Rheumatic Diseases Clinics of North America. 1997;23(3):569–598
  33. Shaw KL, Southwood TR, McDonagh JE. British Society of Paediatric and Adolescent Rheumatology. Growing up and moving on in rheumatology: a multicentre cohort of adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford). 2005;44(6):806–812
  34. Andersson-Gäre B, Fasth A. The natural history of juvenile chronic arthritis: a population based study. Outcome. The Journal of Rheumatology. 1995;22:308–319
  35. Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis and Rheumatism. 1997;40:1202–1209
  36. Ruperto N, Murray KJ, Gerloni V, et al. Pediatric Rheumatology International Trials Organization. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis and Rheumatism. 2004;50:2191–2201
  37. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. New England Journal of Medicine. 2000;342:763–769
  38. Brunner HI, Lovell DJ, Finck BK, Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. The Journal of Rheumatology. 2002;29:1058–1064
  39. Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J. The juvenile-onset spondyloarthritides: rationale for clinical evaluation. Best Practice & Research Clinical Rheumatology. 2002;16(4):551–572
  40. Wallace CA, Ruperto N, Giannini E. Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. The Journal of Rheumatology. 2004;31(11):2290–2294
  41. Viola S, Felici E, Magni-Manzoni S, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis and Rheumatology. 2005;52(7):2092–2102
  42. Ruperto N, Ravelli A, Pistorio A, et al. Paediatric Rheumatology International Trials Organisation. Cross-cultural adaptation and psychometric evaluation of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) in 32 countries. Review of the general methodology. Clinical and Experimental Rheumatology. 2001;19(4 supplement 23):S1–S9
  43. Hofer M, Ruperto N, Saurenmann R, et al. Paediatric Rheumatology International Trials Organisation. The swiss German and swiss French versions of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ). Clinical and Experimental Rheumatology. 2001;19(4 supplement 23):S151–S157
  44. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. The Journal of Rheumatology. 1994;21:2281–2285
  45. Minden K, Kiessling U, Listing J, et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. The Journal of Rheumatology. 2000;27(9):2256–2263
  46. Klepper SE, Darbee J, Effgen SK, Singsen BH. Physical fitness levels in children with polyarticular juvenile rheumatoid arthritis. Arthritis Care Research. 1992;5:93–100
  47. Giannini MJ, Protas EJ. Aerobic capacity in juvenile rheumatoid arthritis patients and healthy children. Arthritis Care Research. 1991;4:131–135
  48. Henderson CJ, Lovell DJ, Specker BL, Campaigne BN. Physical activity in children with juvenile rheumatoid arthritis: quantification and evaluation. Arthritis Care Research. 1995;8:114–119
  49. Huygen AC, Kuis W, Sinnema G. Psychological, behavioural, and social adjustment in children and adolescents with juvenile chronic arthritis. Annals of the Rheumatic Diseases. 2000;59:276–282
  50. Klepper SE. Effects of an eight-week physical conditioning program on disease signs and symptoms in children with chronic arthritis. Arthritis Care Research. 1999;12:52–60
  51. Takken T, Hemel A, van der Net J, Helders PJ. Aerobic fitness in children with juvenile idiopathic arthritis: a systematic review. The Journal of Rheumatology. 2002;29:2643–2647
  52. Epps H, Ginnelly L, Utley M, et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technology Assessment. 2005;9:39
  53. Burgos-Vargas R, Vazquez-Mellado J, Pacheco-Tena C, et al. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Annals of the Rheumatic Diseases. 2002;61(10):941–942
  54. Woo P, Southwood TR, Prieur AM, et al. Randomised, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Annals of the Rheumatic Diseases. 2000;43(8):1849–1857
  55. Ruperto N, Murray KJ, Gerloni V, et al. Pediatric Rheumatology International Trials Organization. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis and Rheumatology. 2004;50(7):2191–2201
  56. Roychowdhury B, Bintley-Bagot S, Bulgen DY, et al. Is methotrexate effective in ankylosing spondylitis?. Rheumatology (Oxford). 2002;41(11):1330–1332
  57. Van Den Bosch F, Kruithof E, Baeten D, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis and Rheumatology. 2002;46(3):755–765
  58. Brandt J, Khariouzov A, Listing J, et al. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis and Rheumatology. 2003;48(6):1667–1675
  59. Heiberg MS, Nordvag BY, Mikkelsen K, et al. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis and Rheumatology. 2005;52(8):2506–2512
  60. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. New England Journal of Medicine. 2000;342(11):763–769
  61. Lovell DJ, Giannini EH, Reiff A, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis and Rheumatology. 2003;48(1):218–226
  62. Quartier P, Taupin P, Bourdeaut F, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis and Rheumatology. 2003;48(4):1093–1101
  63. Henrickson M, Reiff A. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. The Journal of Rheumatology. 2004;31(10):2055–2061
  64. Tse SM, Burgos-Vargas R, Laxer RM. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthritis and Rheumatology. 2005;52(7):2103–2108

PII: S1521-6942(05)00133-6

doi: 10.1016/j.berh.2005.12.001

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 2 , Pages 315-328 , April 2006

Article Tools